z-logo
Premium
Neurotrophic‐4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures
Author(s) -
Hynes M. A.,
Poulsen K.,
Armanini M.,
Berkemeier L.,
Phillips H.,
Rosenthal A.
Publication year - 1994
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/jnr.490370118
Subject(s) - substantia nigra , dopaminergic , striatum , dopamine , neuroscience , midbrain , neurotrophic factors , biology , parkinson's disease , ventral tegmental area , neurodegeneration , neurotoxin , embryonic stem cell , endocrinology , medicine , central nervous system , receptor , disease , genetics , gene
Parkinson's disease is a prevalent neurological disease characterized by profound and incapacitating movement disorders. A common pathology in Parkinson's patients is degeneration of substantia nigra dopaminergic neurons that innervate the striatum and a corresponding decrease in striatal dopamine content. We now report that NT‐4/5 can prevent the death of rat embryonic substantia nigra dopaminergic neurons in low density, enriched, primary cultures. Furthermore, these neurons express messenger RNA encoding the trkB receptor for NT‐4/5 and transcripts for NT‐4/5 are present in their environment. In addition, we demonstrate that NT‐4/5 protects embryonic dopaminergic neurons from the toxic effects of the neurotoxin MPP+ THUAS, nt‐4/5 could be a physiological survival factor for midbrain dopaminergic neurons and may be useful as a therapeutic agent for parkinson's disease. © 1994 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom